Summary Genetics will be one of the future branches of healthcare. The technology might be complex, but investors shouldn’t dismiss it on that ground. There are already great business models around this technology that should make investors salivate. Usually, the technology field is populated by a special type of investor. Because of the jargon… Read More Illumina: Lower Sequencing Costs Are Unleashing A Genetics Mega-Trend
Conventional wisdom tells us that we should avoid tech stocks in an increasing interest rate scenario. However, tech stocks are fundamental for healthy portfolio returns. As happened before, low debt and well-managed companies should be able to weather higher rates. Tech stocks will get overvalued on a frequent basis. Mainly, because this group is… Read More What To Do With Tech Stocks In A Rising Interest Rate Scenario?